comparemela.com

Latest Breaking News On - Absci corporation nasdaq - Page 2 : comparemela.com

Absci Announces $75M Public Offering to Fuel AI Drug Creation

Absci Corporation, a company utilizing generative AI for drug discovery, announced today an initial public offering of $75M in common stock.

Absci Corporation (ABSI) Announces Proposed Public Offering of Common Stock

Absci Corporation (ABSI) Announces Proposed Public Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

IND submission expected in Q1 2025; Phase 1 trials anticipated to initiate shortly afterVANCOUVER, Wash. and NEW YORK, Feb. 21, 2024 Absci Corporation , a data-first generative AI drug creation.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.